BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1936264)

  • 1. 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo.
    Wang MW; Young AA; Rink TJ; Cooper GJ
    FEBS Lett; 1991 Oct; 291(2):195-8. PubMed ID: 1936264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.
    Young AA; Rink TJ; Wang MW
    Life Sci; 1993; 52(21):1717-26. PubMed ID: 8502117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amylin or CGRP (8-37) fragments reverse amylin-induced inhibition of 14C-glycogen accumulation.
    Deems RO; Cardinaux F; Deacon RW; Young DA
    Biochem Biophys Res Commun; 1991 Nov; 181(1):116-20. PubMed ID: 1958178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide (CGRP) on glucose metabolism in the rat.
    Morishita T; Yamaguchi A; Yamatani T; Nakamura A; Arima N; Yamashita Y; Nakata H; Fujita T; Chiba T
    Diabetes Res Clin Pract; 1992 Jan; 15(1):63-9. PubMed ID: 1541237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor.
    Kreutter DK; Orena SJ; Torchia AJ; Contillo LG; Andrews GC; Stevenson RW
    Am J Physiol; 1993 Apr; 264(4 Pt 1):E606-13. PubMed ID: 8386456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro.
    Tedstone AE; Nezzer T; Hughes SJ; Clark A; Matthews DR
    Biosci Rep; 1990 Aug; 10(4):339-45. PubMed ID: 2249001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors.
    Zhu GC; Dudley DT; Saltiel AR
    Biochem Biophys Res Commun; 1991 Jun; 177(2):771-6. PubMed ID: 1646609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin.
    Pittner RA; Wolfe-Lopez D; Young AA; Beaumont K
    Br J Pharmacol; 1996 Mar; 117(5):847-52. PubMed ID: 8851500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations.
    Giuliani S; Wimalawansa SJ; Maggi CA
    Br J Pharmacol; 1992 Oct; 107(2):510-4. PubMed ID: 1330181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP.
    Silvestre RA; Salas M; Dégano P; Peiró E; Marco J
    Biochem Pharmacol; 1993 Jun; 45(11):2343-7. PubMed ID: 8517876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
    Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
    Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists.
    Beaumont K; Moore CX; Pittner RA; Prickett KS; Gaeta LS; Rink TJ; Young AA
    Can J Physiol Pharmacol; 1995 Jul; 73(7):1025-9. PubMed ID: 8846395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved.
    Beaumont K; Pittner RA; Moore CX; Wolfe-Lopez D; Prickett KS; Young AA; Rink TJ
    Br J Pharmacol; 1995 Jul; 115(5):713-5. PubMed ID: 8548167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes.
    Chantry A; Leighton B; Day AJ
    Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):139-43. PubMed ID: 1649597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple receptors for calcitonin gene-related peptide and amylin on guinea-pig ileum and vas deferens.
    Tomlinson AE; Poyner DR
    Br J Pharmacol; 1996 Mar; 117(6):1362-8. PubMed ID: 8882637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones.
    Riediger T; Schmid HA; Young AA; Simon E
    Brain Res; 1999 Aug; 837(1-2):161-8. PubMed ID: 10433998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats.
    Vine W; Beaumont K; Gedulin B; Pittner R; Moore CX; Rink TJ; Young AA
    Eur J Pharmacol; 1996 Oct; 314(1-2):115-21. PubMed ID: 8957226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of liver CGRP/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylin.
    Stephens TW; Heath WF; Hermeling RN
    Diabetes; 1991 Mar; 40(3):395-400. PubMed ID: 1847887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus.
    Haynes JM; Hodgson WC; Cooper ME
    Diabetologia; 1997 Mar; 40(3):256-61. PubMed ID: 9084962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-insulin effects of amylin and calcitonin-gene-related peptide on hepatic glycogen metabolism.
    Gómez-Foix AM; Rodriguez-Gil JE; Guinovart JJ
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):607-10. PubMed ID: 1905922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.